![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Wyeth |
Information provided by: | Wyeth |
ClinicalTrials.gov Identifier: | NCT00340327 |
The purpose of this study is to evaluate the safety and drug levels for single, ascending doses of IMA-638 in healthy Japanese subjects.
Condition | Intervention | Phase |
Healthy |
Drug: IMA-638 |
Phase I |
Study Type: | Interventional |
Study Design: | Diagnostic, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety Study |
Official Title: | An Ascending Single Dose Study of the Safety and Pharmacokinetics of IMA-638 Administered to Healthy Japanese Subjects |
Study Start Date: | June 2006 |
Study Completion Date: | July 2007 |
Ages Eligible for Study: | 20 Years to 45 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Study ID Numbers: | 3174K1-101 |
First Received: | June 16, 2006 |
Last Updated: | December 3, 2007 |
ClinicalTrials.gov Identifier: | NCT00340327 |
Health Authority: | United States: Food and Drug Administration |
|
|
![]() |